Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ZBH

Zimmer Biomet’s Q3 2025 Earnings: What to Expect

Zimmer Biomet is poised to report its fourth-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings.

Barchart

Zimmer Biomet Stock: Is ZBH Underperforming the Health Care Sector?

Despite Zimmer Biomet's underperformance relative to the broader healthcare sector over the past year, the stock is still viewed by analysts with moderate optimism.

Barchart

Zimmer Biomet Stock: Analyst Estimates & Ratings

Zimmer Biomet has significantly underperformed the broader market and other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Zimmer Biomet Stock Underperforming the Dow?

Although Zimmer Biomet has lagged behind the Dow over the past year, analysts remain moderately optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like Zimmer Biomet Stock?

While Zimmer Biomet has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.

Benzinga

What You Need To Know Ahead of Zimmer Biomet's Earnings Release

Zimmer Biomet is expected to announce its second-quarter results in the upcoming month, and analysts expect a low-single-digit drop in earnings.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Monday agreed to acquire Monogram Technologies Inc. (NASDAQ:MGRM) for an upfront payment of $4.04 per share, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million.

Benzinga

Is Zimmer Biomet Stock Underperforming the Nasdaq?

Zimmer Biomet has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Zimmer Biomet Stock Outlook: Is Wall Street Bullish or Bearish?

Zimmer Biomet has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

What to Expect From Zimmer Biomet's Next Quarterly Earnings Report

Zimmer Biomet is gearing up to report its first-quarter results next month, with market expectations pointing to a single-digit decrease in earnings.

Barchart

Zimmer Biomet Hits 34th 52-Week Low: Value Play or Value Trap?

Zimmer Biomet hit its 34th 52-week low on Tuesday. Its shares have decreased by over 20% in the past year. Trading at just 11.8x the 2025 EPS estimate, the maker of orthopedic medical devices looks cheap.

Barchart

Is Zimmer Biomet Stock Outperforming the S&P 500?

Zimmer Biomet has recently surged past the S&P 500 Index, with analysts maintaining a cautiously upbeat outlook on its growth potential.

Barchart

1 Stock to Buy ASAP to Cash in on the Pickleball Craze

As pickleball injuries rise, this medical device stock is perfectly positioned to cash in on the sport’s booming popularity.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Healthtech Stocks Making Healthcare More Accessible

The healthcare market is fueling digital transformation by improving efficiency and fostering personalized care, making it an attractive investment opportunity. Hence, investors might consider investing in healthcare stocks, such as Teladoc Health (TDOC), Zimmer Biomet Holdings (ZBH), and Cardinal Health (CAH). Read more….

Barchart

Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink?

Despite trailing the broader market over the past year, Zimmer Biomet still holds a moderately favorable outlook among analysts.

Barchart

What to Expect From Zimmer Biomet’s Q4 2024 Earnings Report

Zimmer Biomet will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

StockNews.com

3 Healthcare Innovators Advancing Medical Technology

The healthcare industry is set for growth due to evolving healthcare demands and the rapid evolution of medical technologies. Hence, investors might consider investing in healthcare stocks, Becton, Dickinson and Co. (BDX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC). Read more….

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks?

Zimmer Biomet Holdings has significantly underperformed other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.

MarketBeat

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

StockNews.com

3 Healthcare Technology Companies Revolutionizing Patient Care

The healthcare technology market is well-poised for long-term growth, thanks to the growing demand for medical devices, cutting-edge technologies, and changing patient care systems. Thus, it could be wise to buy fundamentally solid healthcare technology stocks Zimmer Biomet Holdings (ZBH), STERIS (STE), and Tactile Systems Technology (TCMD), which are revolutionizing…

Barchart

Is Wall Street Bullish or Bearish on Zimmer Biomet Stock?

While Zimmer Biomet has lagged behind the broader market over the past year, analysts continue to hold a moderately positive view on the stock's prospects.

StockNews.com

3 Undervalued Health-Tech Stocks to Buy for Long-Term Growth

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical areas, as well as the demand for personalized medicine. Thus, it could be wise to invest in fundamentally solid health-tech stocks McKesson (MCK), Cardinal Health (CAH), and Zimmer Biomet (ZBH) poised for long-term…

StockNews.com

3 Medical Devices Stocks Poised for Solid Growth

The medical device sector is evolving, driven by rising demand for precision technology in diagnostics. Therefore, it could be ideal to buy fundamentally solid medical device stocks Stryker Corp (SYK), Axogen (AXGN), and Zimmer Biomet Holdings (ZBH), which look poised for substantial growth. Read more….

Barchart

Here's What to Expect From Zimmer Biomet Holdings' Next Earnings Report

Zimmer Biomet Holdings is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings growth.

1 2

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

338,804 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.